ICG- Livertest Versus New Biomarkers as Prognostic Markers in Critically Ill ICG- Livertest Versus New Biomarkers as Prognostic Markers in Critically Ill

ICG- Livertest Versus New Biomarkers as Prognostic Markers in Critically Ill

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01317381

Acronym

(Greenpep)

Enrollment

100

Registered

2011-03-17

Start date

2010-05-31

Completion date

2011-05-31

Last updated

2011-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Critically Ill Patients

Brief summary

ICG- Leberfunktionstest versus neue Biomarker als prognostischer Marker bei intensivmedizischen Patienten

Interventions

PROCEDUREObservational

Blood draw

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

Gruppe 1: * Intensiv-Patienten mit Verbrennungen \> 10% der Körperoberfläche * Alter \> 18 Gruppe 2: * Intensivpatienten nach grossen chirurgischen Eingriffen * Alter \> 18 Gruppe 3: * Polytraumatisierte, intensivpflichtige Patienten * Alter \> 18

Exclusion criteria

• Alter \< 18 * Schwangerschaft * Einschluss in eine andere Studie * Moribunde Patienten * Patienten, die kein Deutsch verstehen * Jodunverträglichkeit

Countries

Switzerland

Contacts

Primary Contact01 Studienregister MasterAdmins

+41 (0)44 255 11 11

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026